MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells

Cellular Physiology and Biochemistry

Volumn 33, Issue 2, 2014, Pages 402-412

  Pan, Weibo ^a   Wang, Haibao ^a   Jianwei, Ruan ^a   Ye, Zhaoming ^b  

^a TAIZHOU UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Invasion; MAP2K4; MG63 cells; Migration; miR 27a; Osteosarcoma; Proliferation

Indexed keywords

MICRORNA; MICRORNA 27A; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE 1; UNCLASSIFIED DRUG; ONCOPROTEIN; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE;

3' UNTRANSLATED REGION; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL INVASION; CELL INVASION ASSAY; CELL MIGRATION; CELL MIGRATION ASSAY; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; COLONY FORMATION; CONTROLLED STUDY; ENZYME INHIBITION; EXPRESSION VECTOR; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; MUTANT; ONCOGENE; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; WILD TYPE; DRUG TARGETING; ENZYME PHOSPHORYLATION; GENE EXPRESSION; METASTASIS INHIBITION; METASTASIS POTENTIAL; MG63 CELL LINE; OSTEOSARCOMA CELL LINE; TUMOR INVASION;

BONE NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; MAP KINASE KINASE 4; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; OSTEOSARCOMA; RNA, NEOPLASM;

EID: 84895565027     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000356679     Document Type: Article

References (31)

1. Bacci G, Longhi A, Versari M, Mercuri M, Briccoli A, Picci P: Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Cancer 2006;106:1154-1161.
2. Gereige R, Kurnar M: Bone lesions: Benign and malignant. Pediatr Rev 2010;31:355-362; quiz 363.
3. Liu J, Guo W, Yang RL, Tang XD, Yang Y: [Prognostic factors for 72 patients with osteosarcoma of the extremity treated with neoadjuvant chemotherapy]. Zhonghua Wai Ke Za Zhi 2OO846:1166-117O.
4. Yan K, Gao J, Yang T, Ma Q, Qiu X, Fan Q Ma B: MicroRNA-34a inhibits the proliferation and metastasis of osteosarcorna cells both in vitro and invivo. PLoS One 2012;7:e33778.
5. Zhang G, Li M, Jin J, Bai Y, Yang C: Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinasc-9. Asian Pac J Cancer Prey 2011;12:2075-2080.
6. Li Y, Kong D, Wang Z, Sarkar FR: Regulation of microRNAs by natural agents: An emerging field in chemoprevention and chemotherapy research. Pharm Res 2010;27:1027-104 1.
7. Chiang HR, Schoenfeld LW, RubyJG, Auyeung VC, Spies N, Back D, Johnston WK, Russ C, Luo S, Babiarz JE, Blelloch R, Schroth GP, Nusbaum C, Bartel DP: Mammalian microRNAs: Experimental evaluation of novel and previously annotated genes. Genes Dcv 2010;24:992-1009.
8. Ziyan W, Shuhua Y, Xiufang W, Xiaoyun L: MicroRNA-2 1 is involved in osteosarcoma cell invasion and migration. Med Oncol 2011;28: 1469-1474.
9. Kobayashi E, Hornicek FJ, Duan Z: MicroRNA Involvement in Osteosarcoma. Sarcoma 2012;2012:359739.
10. Lulla RR, Costa FF, Bischof JM, Chou PM, de F Bonaldo M, Vanin EF, Soares MB: Identification of Differentially Expressed MicroRNAs in Osteosarcoma. Sarcoma 2011;2011:732690.
11. Osaki M, Takeshita F, Sugimoto Y, Kosaka N, Yamamoto Y, Yoshioka Y, Kohayashi E, Yamada T, Kawai A, Inoue T, Ito H, Oshimura M, Ochiya T: MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression. Mol Ther 2011; 19:11234130.
12. Guttilla 1K, White BA: Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem 2009;284:23204-23216.
13. Mertens-Talcott SU, Chintharlapalli S, Li X, Safe 5: The oncogenic microRNA-2 7a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDAMB-231 breast cancer cells. Cancer Res 2007;67:11001-11011.
14. Liu T, Tang H, Lang Y, Liu M, Li X: MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett 2009;273:233-242.
15. Chintharlapalli S, Papineni 5, Abdelrahim M, Abudayyeh A, Jutooru I, Chadalapaka G, Wu F, MertensTalcott S, Vanderlaag K, Cho SD, Smith R 3rd, Safe S: Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-i8beta-olean-1,12-dien-30-oate in colon cancer cells. IntJ Cancer 2009;125:1965-1974.
16. Jones KB, Salah Z, Del MS, Galasso M, Gaudio E, Nuovo GJ, Lovat F, LeBlanc K, PalatiniJ, Randall RL, Volinia S, Stein GS, Croce CM, Lian JE, Aqeilan RI: MiRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res 2012;72:1865-1877.
17. Hordegen P, Cabaret J, Hertzberg H, Langhans W, Maurer V: In vitro screening of six anthelmintic plant products against larval Haemonchus contortus with a modified methyl-Thiazolyl-Tetrazolium reduction assay. J Ethnopharmacol 2006;108:85-89.
18. XinW, Yun KJ, Ricci F, Zahurak M, Qiu W, Su GH, Yeo CJ, Hruhan RH, Kern SE, Iacobuzio-Donahue CA: MAP2K4/MKK4 expression in pancreatic cancer: Genetic validation of immunohistochemistry and relationship to disease course. Clin Cancer Res 2004;10:8516-8520.
19. Deng S, Calm GA, Croce CM, Coukos G, Zhang L: Mechanisms of microRNA deregulation in human cancer. Cell Cycle 2008;7:2643-2646.
20. Sun Q Gu H, Zeng Y, Xia Y, Wang Y, Jing Y, Yang L, Wang B: Hsa-rnir-2 7a genetic variant contributes to gastric cancer susceptibility through affecting miR-27a and target gene expression. Cancer Sci 2010;101:2241-2247.
21. MaY, Yu 5, Zhao W Lu Z, Chen J: RniR-27a regulates the growth, colony formation and migration of pancreatic cancer cells bytargeting Sprouty2. Cancer Lett 2010;298:150-158.
22. Rodriguez MC, Petersen M, Mundy J: Mitogen-Activated protein kinase signaling in plants. Annu Rev Plant Biol 2010;61:621-649.
23. Whitmarsh AJ, Davis RI: Role of mitogen-Activated protein kinase kinase 4 in cancer. Oncogene 2007;26:3 172-3 184.
24. Hickson JA, Huo D, Vander GDJ, Lin A, Rinker-Schaeffer CW, Yamada SD: The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma. Cancer Res 2006;66:2264-2270.
25. Kennedy NJ, Sluss HK, Jones SN, Bar-Sagi D, Flavell RA, Davis RI: Suppression of Ras-stimulated transformation by the JNK signal transduction pathway. Genes Dcv 2003; 17:629-637.
26. Khatlani TS, Wislez M, Sun M, Srinivas H, Iwanaga K, Ma L, Hanna AE, Liu D, Girard L, Kim YH, Pollack JR, Minna JD, Wistuba II, Kuric JM: C-Jun N-Terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells. Oncogene 2007;26:2658-2666.
27. Lotan T, Hickson J, Souris J, Huo D, Taylor 1 LiT, Otto K, Yarnada SD, Macleod K, Rinker-Schaeffer CW: C-Jun NH2-Tcrminal kinase activating kinase 1/mitogen-Activated protein kinase kinase 4-mediated inhibition of SKOV3ip.1 ovarian cancer metastasis involves growth arrest and p21 up-regulation. Cancer Res 20 08; 6 8:2 16 6-2 175.
28. Wang L, Pan Y, Dai JL: Evidence of MKK4 pro-oncogenic activity in breast and pancreatic tumors. Oncogene 2004;2 3:5978-5985.
29. Cunningham SC, Gallmeier E, Huci T, Dezentje DA, Abdelmohsen K, Gorospe M, Kern SE: Theoretical proposal: Allele dosage of MAP2K4/MKK4 could rationalize frequent i7p loss in diverse human cancers. Cell Cycle 2006;5:1090-1093.
30. Davis SJ, Choong DY, Ramakrishna M, Ryland GL, Campbell IG, Gorringe KL: Analysis of the mitogenactivated protein kinase kinase 4 (MAP2K4J tumor suppressor gene in ovarian cancer. BMC Cancer 2011;1i:173.
31. Ahn YH, Yang Y, Gibbons DL, Creighton CJ, Yang F, Wistuba II, Lin W, Thilaganathan N, Alvarez CA, Roybal J, Goldsmith EJ, Tournier C, IKurie JM: Map2k4 functions as a tumor suppressor in lung adenocarcinoma and inhibits tumor cell invasion by decreasing peroxisome proliferator-Activated receptor gamrna2 expression. Mol Cell Biol 2011;31:4270-4285.